Cancer Research UK logo.
SearchDonate
  • Search

Chronic myeloid leukaemia (CML)

Survival for chronic myeloid leukaemia (CML)

Survival for chronic myeloid leukaemia (CML) depends on several factors such as age. CML is usually a slow developing condition that can be kept under control for many years.

Your doctor might tell you that you can expect to have the same length of life as people without CML. But some people are diagnosed in the accelerated or blast phase. Unfortunately it can be harder to control this stage of CML.

​ called ​​ generally work very well to control CML. People can go into remission for many years. This is when the disease isn’t active, you don't have symptoms and there are no signs of CML in your tests. 

Below are general statistics based on large groups of people. Remember, they can’t tell you what will happen in your individual case. 

About these statistics

The terms 1 year survival and 5 year survival don't mean that you will only live for 1 or 5 years.

The NHS, other health organisations, and researchers collect information. They record what happens to people with cancer in the years after their diagnosis. 5 years is a common time point to measure survival. But some people live much longer than this.

5 year survival is the number of people who have not died from their cancer within 5 years after diagnosis.

Survival statistics

No UK-wide statistics are available for CML survival. Statistics are available for people diagnosed with CML in England between 2014 and 2016.

Generally for all people with CML:

  • more than 90 out of 100 people (more than 90%) will survive their CML for 1 year or more after being diagnosed

  • 80 out of 100 people (80%) will survive their CML for 5 years or more after being diagnosed

This is for all ages. Younger people tend to do slightly better than older people. 

Remember that most people don't die from their leukaemia. When they do die, its is from conditions unrelated to their leukaemia.

For those younger than 70: 

  • more than 90 out of 100 (more than 90%) will survive their CML for 5 years or more after diagnosis

For those who are 70 or older:

  • around 55 out of 100 people (around 55%) will survive their CML for 5 years or more after diagnosis

What affects survival

Your outlook depends on how well the treatment works, and how well your body copes with the treatment side effects. It also depends on your general health and whether you have any other illnesses.

Several factors can affect your outlook (prognosis). These are called prognostic factors. Doctors can look at these prognostic factors to predict how you might respond to treatment. Some of these factors include:

  • your age - younger people have a better prognosis

  • having a low ​​ count

  • how many blasts you have in your blood – blasts are new, immature blood cells

  • how large your ​​ is

  • changes to

Read about treatment for CML

More statistics

For more in-depth information about survival and CML, go to Cancer Research UK's Cancer Statistics section.

Last reviewed: 23 Jun 2025

Next review due: 23 Jun 2028

What is CML?

Chronic myeloid leukaemia (CML) is a type of cancer that affects the blood and bone marrow. It usually develops very slowly.

Stages (phases) of CML

There are 2 systems to describe how far your CML has developed. You might have 2 or 3 phases. At the moment CML is mainly described using 3 phases. These are chronic, accelerated and blast. Knowing the phase helps your doctor decide which treatment you need.

Getting diagnosed with CML

You usually start by seeing your GP if you have symptoms that could be due to CML. Or your GP might arrange to see you if you have had an abnormal blood test result. They will then decide whether to refer you for further tests or to see a specialist.

Treatment for CML

Targeted cancer drugs called tyrosine kinase inhibitors (TKIs) are the main treatment for CML. Find out more about your treatment options, the different treatments and how they monitor treatment is working.

Living with CML

Chronic myeloid leukaemia (CML) is often a slowly developing condition. Treatment can keep it under control for many years. Find out how to cope and what support is available.

CML main page

CML starts in the white blood cells called granulocytes. It often develops slowly and treatment can keep it under control for many years. Find out more.

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and Support

An icon of a hand shake.

Find a Clinical Trial

Search our clinical trials database for all cancer trials and studies recruiting in the UK.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.